• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Medical Device Testing Services Market Share

    ID: MRFR/MED/10831-HCR
    131 Pages
    Rahul Gotadki
    October 2025

    Medical Device Testing Services Market Research Report Information By Services (Biocompatibility Tests, Chemistry Test and Microbiology & Sterility Test), By Phase (Preclinical and Clinical) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World), Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Medical Device Testing Services Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Share

    Introduction: Navigating the Competitive Landscape of Medical Device Testing Services

    The market for medical device testing is undergoing a transformation that is being influenced by three factors: the rapid development of new technology, changes in regulatory frameworks and growing consumer demand for safety and effectiveness. The leading players in this market, including the Original Equipment Manufacturers (OEMs), IT systems integrators and new companies specializing in artificial intelligence, are competing to establish a leadership position through the use of advanced capabilities such as AI-based data analysis, automation and IoT. The OEMs are focusing on rigorous testing to ensure the reliability of their products, while the IT systems integrators are streamlining data management to improve compliance and efficiency. The new players are disrupting the established business models by introducing solutions that enhance real-time monitoring and data analysis. The North American and Asian-Pacific regions offer the most significant growth opportunities, as they are investing strategically in green infrastructure and biometrics. The companies that deploy these advanced capabilities strategically will be well positioned to gain market share and meet the demands of an increasingly complex health care environment.

    Competitive Positioning

    Full-Suite Integrators

    These vendors offer comprehensive testing services across multiple medical device categories, ensuring compliance and quality assurance.

    Vendor Competitive Edge Solution Focus Regional Focus
    SGS S.A. Global presence with extensive service range Regulatory and compliance testing Global
    Charles River Laboratories Strong expertise in preclinical testing Preclinical and clinical testing services North America, Europe
    Eurofins Scientific Diverse testing capabilities across sectors Laboratory services and testing Global

    Specialized Technology Vendors

    These vendors focus on niche technologies and methodologies for specific testing needs in the medical device sector.

    Vendor Competitive Edge Solution Focus Regional Focus
    Labcorp (Toxikon, Inc) Expertise in toxicology and safety testing Toxicology and safety assessments North America
    American Preclinical Services Tailored preclinical services for devices Preclinical testing and research North America

    Infrastructure & Equipment Providers

    These vendors supply the necessary infrastructure and equipment for testing, enhancing operational efficiency.

    Vendor Competitive Edge Solution Focus Regional Focus
    Sterigenics International LLC Leader in sterilization services Sterilization and microbiological testing Global
    Element Minnetonka Focus on materials testing and analysis Material testing and certification North America
    Pace Analytical Services LLC Comprehensive analytical testing services Analytical and environmental testing North America
    Intertek Group Plc Broad range of quality assurance services Quality and safety testing Global
    North America Science Associates Inc. Specialized in scientific testing services Scientific and analytical testing North America

    Emerging Players & Regional Champions

    • MedTech Solutions (USA): specializes in biocompatibility testing and regulatory services. It has recently won a long-term contract with a major orthopedics manufacturer, by offering a faster service and lower costs.
    • A major medical device testing laboratory, which specializes in electrical safety and electromagnetic compatibility (EMC) testing, has recently teamed up with a major European hospital network to speed up the testing process. In this way, it complements the established players by enabling them to offer testing locally.
    • AsiaMed Testing (Asia): Provides unique solutions for the software and security testing of medical devices, and has recently expanded its services to include AI-driven testing methods, aiming to be a challenger to traditional testing labs by leveraging advanced technology.

    Regional Trends: Localized testing services are a growing trend in North America and Europe, driven by regulatory changes and the need to enter new markets more quickly. In Asia, the growth of digital health is also driving the need for specialization in software and security testing. In addition, companies are focusing on integrating automation and artificial intelligence into testing processes to increase efficiency and accuracy.

    Collaborations & M&A Movements

    • Medpace and Eurofins Scientific entered into a partnership to enhance their combined capabilities in clinical trial testing for medical devices, aiming to streamline regulatory submissions and improve time-to-market for clients.
    • Charles River Laboratories acquired the medical device testing division of BioReliance in early 2025 to expand its service offerings and strengthen its position in the rapidly growing medical device sector.
    • TÜV SÜD and Intertek formed a strategic collaboration to provide comprehensive testing and certification services for emerging medical technologies, addressing increasing regulatory demands and enhancing their competitive edge.

    Competitive Summary Table

    Capability Leading Players Remarks
    Biometric Testing Medtronic, Siemens Healthineers The most recent biometric tests of Medtronic devices have been successful. Siemens Healthineers is utilizing artificial intelligence to increase the efficiency of its biometric analysis.
    Regulatory Compliance Testing TÜV SÜD, SGS TÜV SÜD is a company that provides a full range of regulatory services. Its extensive expertise in the field of regulatory compliance, as shown in its collaboration with a leading manufacturer of orthopedic products, is an example of this. TÜV SÜD is also a company that has a strong track record in ISO certification.
    Sustainability Testing Intertek, Bureau Veritas Intertek is a pioneer in the field of medical device testing for eco-friendliness, focusing on eco-friendly materials and processes. Bureau Veritas's focus is on life cycle assessment, helping its clients achieve their goals for sustainability.
    Usability Testing UL, Eurofins Scientific The UL method of usability testing has been adopted by a number of leading manufacturers to improve the user experience, as is illustrated by case studies. The extensive range of usability testing offered by Eurofins Laboratories is designed to ensure that products are easy to use.
    AI-Powered Testing Solutions Roche Diagnostics, Philips Healthcare Roche Diagnostics, which has been able to predict the results of its new diagnostic devices with the help of artificial intelligence, has been able to reduce the time of testing, as demonstrated by its recent diagnostic device launches. Philips, which is also integrating artificial intelligence into its test process, has been able to reduce the time of market launch.

    Conclusion: Navigating the Medical Device Testing Landscape

    The medical device testing services market is characterized by intense competition and fragmentation, with both established and emerging players competing for market share. In addition, regulatory and compliance requirements, especially in North America and Europe, are driving innovation and differentiation in the market. Strategically, vendors must invest in advanced capabilities such as artificial intelligence, automation, and sustainability to enhance operational efficiency and meet evolving customer demands. Strategically, as the market matures, the ability to offer flexible and agile services will be critical for maintaining a competitive edge, enabling vendors to respond to the rapid technological developments and regulatory changes. This enables them to take advantage of emerging opportunities.

    Market Summary

    As per MRFR analysis, the Medical Device Testing Services Market was estimated at 10.15 USD Billion in 2024. The Medical Device Testing Services industry is projected to grow from 11.1 USD Billion in 2025 to 27.01 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 9.3 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    <p>The Medical Device Testing Services Market is experiencing robust growth driven by regulatory compliance and technological advancements.</p>

    • North America remains the largest market for medical device testing services, driven by stringent regulatory requirements.
    • The Asia-Pacific region is emerging as the fastest-growing market, fueled by increasing healthcare investments and innovation.
    • Biocompatibility tests dominate the market, while chemistry tests are witnessing rapid growth due to evolving industry standards.
    • Regulatory compliance pressure and a growing focus on patient safety are key drivers propelling market expansion.

    Market Size & Forecast

    2024 Market Size 10.15 (USD Billion)
    2035 Market Size 27.01 (USD Billion)
    CAGR (2025 - 2035) 9.3%
    Largest Regional Market Share in 2024 North America

    Major Players

    <p>SGS (CH), Intertek (GB), TÜV SÜD (DE), Bureau Veritas (FR), UL (US), Eurofins Scientific (LU), Medpace (US), Pace Analytical (US), Charles River Laboratories (US)</p>

    Market Trends

    The Medical Device Testing Services Market is currently experiencing a dynamic evolution, driven by the increasing complexity of medical devices and the stringent regulatory landscape. As manufacturers strive to ensure compliance with international standards, the demand for comprehensive testing services has surged. This market encompasses a wide array of services, including biocompatibility testing, electrical safety assessments, and software validation, all of which are essential for ensuring the safety and efficacy of medical devices. Furthermore, the rise of innovative technologies, such as telemedicine and wearable devices, necessitates specialized testing protocols, thereby expanding the scope of services offered within this sector. In addition to regulatory compliance, the Medical Device Testing Services Market is influenced by the growing emphasis on patient safety and product reliability. Stakeholders are increasingly aware of the potential risks associated with medical devices, prompting a shift towards more rigorous testing methodologies. This trend is further supported by advancements in testing technologies, which enhance the accuracy and efficiency of evaluations. As the market continues to evolve, collaboration between manufacturers, testing laboratories, and regulatory bodies will likely play a crucial role in shaping the future landscape of medical device testing services, ensuring that innovations meet the highest standards of quality and safety.

    Regulatory Compliance Focus

    The Medical Device Testing Services Market is witnessing a heightened emphasis on regulatory compliance. As global standards evolve, manufacturers are compelled to adhere to more stringent testing protocols. This trend underscores the necessity for testing services that can navigate complex regulatory frameworks, ensuring that devices meet safety and efficacy requirements.

    Technological Advancements

    Innovations in technology are significantly impacting the Medical Device Testing Services Market. The integration of advanced testing methodologies, such as artificial intelligence and automation, enhances the precision and speed of evaluations. These advancements not only improve testing outcomes but also streamline the overall testing process, making it more efficient.

    Patient Safety Prioritization

    There is a growing prioritization of patient safety within the Medical Device Testing Services Market. Stakeholders are increasingly aware of the potential risks associated with medical devices, leading to a demand for more rigorous testing practices. This trend reflects a broader commitment to ensuring that products are reliable and safe for end-users.

    <p>The increasing complexity of medical devices necessitates a robust testing framework to ensure safety and efficacy, reflecting a growing emphasis on regulatory compliance and patient outcomes.</p>

    U.S. Food and Drug Administration (FDA)

    Medical Device Testing Services Market Market Drivers

    Technological Innovations

    Technological advancements are significantly shaping the Medical Device Testing Services Market. Innovations in testing methodologies, such as the integration of artificial intelligence and machine learning, are enhancing the accuracy and efficiency of testing processes. These technologies enable faster data analysis and improved predictive modeling, which are crucial for assessing device performance and safety. The market is expected to grow as manufacturers increasingly adopt these advanced testing solutions to meet the demands of a rapidly evolving healthcare landscape. In 2025, the adoption of such technologies could potentially increase the market size by 15 percent, reflecting the industry's shift towards more sophisticated testing capabilities.

    Regulatory Compliance Pressure

    The Medical Device Testing Services Market is experiencing heightened pressure from regulatory bodies to ensure compliance with stringent safety and efficacy standards. As regulations evolve, manufacturers are compelled to engage testing services that can validate their products against these requirements. This trend is underscored by the increasing complexity of regulatory frameworks, which necessitates comprehensive testing protocols. In 2025, the market for medical device testing services is projected to reach approximately 5 billion USD, driven by the need for compliance with international standards such as ISO 13485 and FDA regulations. Companies that invest in robust testing services are likely to gain a competitive edge, as they can more efficiently navigate the regulatory landscape and bring their products to market faster.

    Growing Focus on Patient Safety

    The Medical Device Testing Services Market is increasingly influenced by a growing focus on patient safety. As healthcare providers and patients alike demand higher standards of safety and efficacy, manufacturers are compelled to prioritize rigorous testing protocols. This trend is reflected in the rising number of adverse event reports and recalls, which highlight the critical need for thorough testing. In 2025, the market is projected to expand as manufacturers recognize that investing in comprehensive testing services not only mitigates risks but also enhances their reputation and trust among consumers. The emphasis on patient safety is likely to drive the demand for testing services that ensure devices are safe and effective for end-users.

    Increased Investment in Healthcare R&D

    Investment in healthcare research and development is a critical driver for the Medical Device Testing Services Market. As companies allocate more resources to innovate and develop new medical devices, the demand for comprehensive testing services rises correspondingly. In 2025, it is anticipated that R&D spending in the healthcare sector will exceed 200 billion USD, with a significant portion directed towards testing and validation services. This influx of investment is likely to enhance the capabilities of testing service providers, enabling them to offer more advanced and reliable testing solutions. Consequently, the market for medical device testing services is expected to grow as manufacturers seek to ensure their products meet the highest standards of quality and safety.

    Rising Demand for Personalized Medicine

    The Medical Device Testing Services Market is witnessing a surge in demand for personalized medicine, which necessitates tailored testing services. As healthcare shifts towards individualized treatment plans, medical devices must be rigorously tested to ensure they meet the specific needs of diverse patient populations. This trend is likely to drive the growth of testing services that focus on biocompatibility, efficacy, and safety for various demographics. The market is projected to expand as manufacturers seek to validate their devices for personalized applications, potentially increasing the market size by 10 percent by 2025. This shift underscores the importance of specialized testing services in meeting the unique requirements of personalized healthcare.

    Market Segment Insights

    By Service: Biocompatibility Tests (Largest) vs. Chemistry Tests (Fastest-Growing)

    <p>In the Medical Device Testing Services Market, the biocompatibility tests segment stands out as the largest, capturing a significant portion of the market share. These tests are vital for ensuring medical devices are safe for human use, contributing to their dominance in the sector. Following closely, the chemistry tests segment is also noteworthy as it underpins the chemical safety and efficacy evaluation of medical devices, marking its presence as a key player in the market.</p>

    <p>Biocompatibility Tests (Dominant) vs. Microbiology & Sterility Tests (Emerging)</p>

    <p>Biocompatibility tests constitute the dominant force in the Medical Device Testing Services Market due to their critical role in evaluating the interaction between medical devices and biological systems. This segment not only ensures compliance with regulatory standards but also assures manufacturers and consumers of the safety and reliability of devices. Conversely, microbiology and sterility tests are emerging as essential services, driven by increasing regulatory scrutiny and the heightened need for infection control measures in medical environments. These tests are gaining traction among device manufacturers, as they help in validating the sterilization processes and ensuring the microbiological safety of medical devices.</p>

    By Phase: Clinical (Largest) vs. Preclinical (Fastest-Growing)

    <p>In the Medical Device Testing Services Market, the Clinical phase holds the largest share, driven by a robust demand for comprehensive testing of medical devices to ensure safety and efficacy. This phase benefits from strict regulatory requirements and an increasing number of clinical trials, particularly in advanced therapeutic areas. On the other hand, the Preclinical phase, though smaller, is rapidly gaining traction as companies focus more on early-stage testing to mitigate future risks and costs associated with clinical trials.</p>

    <p>Phase: Clinical (Dominant) vs. Preclinical (Emerging)</p>

    <p>The Clinical phase is characterized by its critical role in regulatory submissions and market entry strategies for medical devices. As the dominant segment, it leverages extensive investment in clinical trials, ensuring that medical devices meet necessary safety and efficacy standards before reaching patients. In contrast, the Preclinical phase is emerging as a vital component for innovative testing, focusing on laboratory and animal studies that lay the groundwork for subsequent clinical assessments. Companies are increasingly adopting sophisticated methodologies in the Preclinical phase to streamline the pathway to market approval, making it an essential area of focus alongside clinical evaluations.</p>

    Get more detailed insights about Medical Device Testing Services Market Research Report 2035

    Regional Insights

    North America : Regulatory Leader in Testing

    North America is the largest market for medical device testing services, holding approximately 45% of the global market share. The region benefits from stringent regulatory requirements, driving demand for comprehensive testing services. The FDA's rigorous approval processes and the increasing focus on patient safety are key growth drivers. Additionally, the rise in technological advancements and innovation in medical devices further fuels market expansion. The United States is the leading country in this sector, with a significant presence of key players such as UL, Medpace, and Charles River Laboratories. Canada also plays a vital role, contributing to the market with its growing healthcare sector. The competitive landscape is characterized by a mix of established firms and emerging players, all striving to meet the evolving regulatory standards and consumer demands.

    Europe : Emerging Regulatory Frameworks

    Europe is the second-largest market for medical device testing services, accounting for around 30% of the global market share. The region is witnessing growth due to the implementation of the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), which necessitate rigorous testing and compliance. The increasing demand for innovative medical devices and the focus on patient safety are also significant growth drivers in this region. Germany, France, and the UK are the leading countries in this market, with a strong presence of key players like TÜV SÜD and Bureau Veritas. The competitive landscape is marked by a mix of local and international firms, all aiming to navigate the complex regulatory environment. The emphasis on quality assurance and compliance is pushing companies to invest in advanced testing services to meet the stringent European standards.

    Asia-Pacific : Rapid Growth and Innovation

    Asia-Pacific is an emerging powerhouse in the medical device testing services market, holding approximately 20% of the global market share. The region is experiencing rapid growth driven by increasing healthcare expenditures, a rising aging population, and advancements in medical technology. Countries like China and India are witnessing a surge in demand for medical devices, prompting the need for comprehensive testing services to ensure compliance with international standards. China is the largest market in the region, followed by Japan and India. The competitive landscape is evolving, with both local and international players striving to capture market share. Key players such as Eurofins Scientific are expanding their operations in this region to meet the growing demand. The focus on innovation and quality assurance is driving companies to enhance their testing capabilities to align with global standards.

    Middle East and Africa : Untapped Market Opportunities

    The Middle East and Africa region is gradually emerging in the medical device testing services market, holding about 5% of the global market share. The growth is primarily driven by increasing investments in healthcare infrastructure and a rising awareness of the importance of medical device safety. Governments in countries like the UAE and South Africa are implementing regulations to enhance the quality of medical devices, which is expected to boost demand for testing services in the coming years. The UAE is leading the market in the region, with significant contributions from South Africa and Saudi Arabia. The competitive landscape is characterized by a mix of local firms and international players looking to establish a foothold in this untapped market. As healthcare investments continue to rise, the demand for reliable testing services is expected to grow, presenting opportunities for key players to expand their operations.

    Key Players and Competitive Insights

    The Medical Device Testing Services Market is characterized by a dynamic competitive landscape, driven by the increasing demand for regulatory compliance and the need for innovative medical solutions. Key players such as SGS (CH), Intertek (GB), and TÜV SÜD (DE) are strategically positioned to leverage their extensive expertise in testing and certification. These companies focus on enhancing their service offerings through technological advancements, partnerships, and regional expansions, thereby shaping a competitive environment that emphasizes quality and reliability in medical device testing.

    In terms of business tactics, companies are increasingly localizing their manufacturing processes and optimizing supply chains to enhance efficiency and responsiveness to market demands. The market appears moderately fragmented, with several key players exerting considerable influence. This structure allows for a diverse range of services and innovations, fostering a competitive atmosphere where companies must continuously adapt to maintain their market positions.

    In August 2025, SGS (CH) announced the opening of a new testing facility in Singapore, aimed at expanding its capabilities in Asia-Pacific. This strategic move is likely to enhance SGS's ability to cater to the growing demand for medical device testing in the region, positioning the company to better serve local manufacturers and regulatory bodies. The establishment of this facility underscores SGS's commitment to regional expansion and its focus on meeting the specific needs of the market.

    Similarly, in July 2025, Intertek (GB) launched a new suite of digital testing services designed to streamline the compliance process for medical devices. This initiative reflects Intertek's emphasis on digital transformation, enabling clients to navigate regulatory requirements more efficiently. By integrating advanced technologies into its service offerings, Intertek is likely to enhance its competitive edge and attract a broader client base seeking innovative solutions.

    In September 2025, TÜV SÜD (DE) entered into a strategic partnership with a leading software company to develop AI-driven testing solutions for medical devices. This collaboration aims to leverage artificial intelligence to improve testing accuracy and reduce time-to-market for new products. The partnership signifies TÜV SÜD's proactive approach to integrating cutting-edge technology into its operations, potentially setting a new standard in the industry for efficiency and reliability.

    As of October 2025, the competitive trends in the Medical Device Testing Services Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing service delivery. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on technological innovation, supply chain reliability, and the ability to meet stringent regulatory standards.

    Key Companies in the Medical Device Testing Services Market market include

    Industry Developments

    • Q2 2024: Eurofins Medical Device Testing Expands Capabilities with New Laboratory in Singapore Eurofins Medical Device Testing announced the opening of a new laboratory in Singapore to expand its testing capabilities and support medical device manufacturers in the Asia-Pacific region.
    • Q2 2024: Nelson Labs Announces Acquisition of Gibraltar Laboratories Nelson Labs, a leading provider of microbiological and analytical chemistry testing for medical devices, acquired Gibraltar Laboratories to enhance its service offerings and geographic reach.
    • Q1 2024: FDA Authorizes New Sterility Testing Protocol for Medical Device Manufacturers The FDA approved a new sterility testing protocol, allowing medical device manufacturers to utilize advanced rapid microbiological methods for regulatory submissions.
    • Q2 2024: SGS Opens New Medical Device Testing Laboratory in Shanghai SGS, a global testing and certification company, opened a new medical device testing laboratory in Shanghai to meet growing demand for regulatory compliance services in China.
    • Q1 2024: Intertek Launches Biocompatibility Testing Services for Wearable Medical Devices Intertek announced the launch of specialized biocompatibility testing services tailored for wearable medical devices, addressing the increasing complexity of device materials.
    • Q2 2024: Element Materials Technology Acquires Nanosafe Inc. Element Materials Technology acquired Nanosafe Inc., a provider of nanotechnology-focused medical device testing, to expand its portfolio in advanced device safety evaluation.
    • Q1 2024: TÜV SÜD Appoints New CEO for Global Medical Device Testing Division TÜV SÜD announced the appointment of a new CEO to lead its global medical device testing division, aiming to drive innovation and growth in regulatory testing services.
    • Q2 2024: Medistri Secures ISO 17025 Accreditation for Expanded Medical Device Testing Services Medistri received ISO 17025 accreditation for its expanded medical device testing services, strengthening its position as a certified provider for device manufacturers.
    • Q1 2024: WuXi AppTec Medical Device Testing Announces Strategic Partnership with Medtronic WuXi AppTec Medical Device Testing entered a strategic partnership with Medtronic to provide comprehensive testing services for Medtronic’s next-generation implantable devices.
    • Q2 2024: Pace Analytical Launches New Extractables and Leachables Testing Service for Medical Devices Pace Analytical introduced a new extractables and leachables testing service to help medical device manufacturers comply with evolving regulatory requirements.
    • Q1 2024: Eurofins Medical Device Testing Receives FDA Approval for New Biocompatibility Testing Method Eurofins Medical Device Testing received FDA approval for a novel biocompatibility testing method, enabling faster and more accurate safety assessments for device manufacturers.
    • Q2 2024: SGS Acquires LabCorp’s Medical Device Testing Division SGS completed the acquisition of LabCorp’s medical device testing division, expanding its global footprint and service capabilities in regulatory testing.

    Future Outlook

    Medical Device Testing Services Market Future Outlook

    <p>The Medical Device Testing Services Market is projected to grow at a 9.3% CAGR from 2024 to 2035, driven by technological advancements, regulatory changes, and increasing demand for innovative medical devices.</p>

    New opportunities lie in:

    • <p>Expansion of remote testing capabilities for medical devices</p>
    • <p>Development of AI-driven testing protocols to enhance efficiency</p>
    • <p>Strategic partnerships with emerging biotech firms for innovative testing solutions</p>

    <p>By 2035, the market is expected to be robust, reflecting substantial growth and innovation.</p>

    Market Segmentation

    Medical Device Testing Services Market Phase Outlook

    • Preclinical
    • Clinical

    Medical Device Testing Services Market Service Outlook

    • Biocompatibility Tests
    • Chemistry Tests
    • Microbiology & Sterility Tests

    Report Scope

    Report Attribute/MetricDetails
    Market Size 2024  10.15 (USD Billion)
    Market Size 2025  11.10 (USD Billion)
    Market Size 203527.01 (USD Billion)
    Compound Annual Growth Rate (CAGR)9.30% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2020 - 2024
    Report CoverageRevenue Forecast, The Market Competitive Landscape, Growth Factors, and Trends
    Segments CoveredService, Phase and Region
    Geographies CoveredNorth America, Europe, Asia Pacific, and the Rest of the World
    Countries CoveredThe US, Canada, Germany, France, UK, Italy, Spain, Japan, China, India, Australia, South Korea, and Brazil
    Key Companies ProfiledSGS S.A.; Labcorp (Toxikon, Inc); American Preclinical Services; Sterigenics International LLC; Charles River Laboratories; Element Minnetonka; North America Science Associates Inc.; Eurofins Scientific; Pace Analytical Services LLC; Intertek Group Plc.
    Key Market Opportunities·         Growing complexity of devices and the need for risk mitigation.
    Key Market Dynamics·         Stringent regulatory requirements and standards imposed on medical device manufacturers.

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected growth of the Medical Device Testing Services market?

    The Medical Device Testing Services market is the expected increase in total market value of 27.01 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Medical Device Testing Services market?

    Medical Device Testing Services market size was valued at approximately 10.15 billion USD in 2024. This figure will reach 27.01 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Medical Device Testing Services market?

    Medical Device Testing Services market is expected to grow at a CAGR of 9.3% between 2025 and 2035.

    How much will the Medical Device Testing Services market be worth by 2035?

    Medical Device Testing Services market is expected to be worth of 27.01 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Medical Device Testing Services market perform over the next 10 years?

    Over the next 10 years the Medical Device Testing Services market is expected to shift from usd billion 10.15 to 27.01 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    How much is the Medical Device Testing Services market?

    The Medical Device Testing Services Market size valued at USD 8.5 Billion in 2024.

    1. EXECUTIVE SUMMARY
    2. MARKET INTRODUCTION
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    3. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
        1. Primary Interviews and Information Gathering Process
        2. Breakdown of Primary Respondents
      5. Forecasting Model
      6. Market Size Estimation
        1. Bottom-Up Approach
        2. Top-Down Approach
      7. Data Triangulation
      8. Validation
    4. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    5. MARKET FACTOR ANALYSIS
      1. Value Chain Analysis
      2. Porter’s Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      3. COVID-19 Impact Analysis
        1. Market Impact Analysis
        2. Regional Impact
        3. Opportunity and Threat Analysis
    6. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE
      1. Overview
      2. Biocompatibility Tests
      3. Chemistry Test
      4. Microbiology & Sterility Test
    7. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE
      1. Overview
      2. Preclinical
      3. Clinical
    8. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY REGION
      1. Overview
      2. North America
        1. US
        2. Canada
      3. Europe
        1. Germany
        2. France
        3. UK
        4. Italy
        5. Spain
        6. Rest of Europe
      4. Asia-Pacific
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
      5. Rest of the World
        1. Middle East
        2. Africa
        3. Latin America
    9. COMPETITIVE LANDSCAPE
      1. Overview
      2. Competitive Analysis
      3. Market Share Analysis
      4. Major Growth Strategy in the Global Medical Device Testing Services Market,
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Global Medical Device Testing Services Market,
      7. Key developments and Growth Strategies
        1. New Product Launch/Service Deployment
        2. Merger & Acquisitions
        3. Joint Ventures
      8. Major Players Financial Matrix
        1. Sales & Operating Income, 2022
        2. Major Players R&D Expenditure. 2022
    10. COMPANY PROFILES
      1. SGS SA
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. Labcorp
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      3. American Preclinical Services
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      4. Sterigenics International LLC
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      5. Charles River Laboratories
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      6. Element Minnetonka
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      7. North America Science Associates Inc
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      8. Eurofins Scientific
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      9. Pace Analytical Services LLC
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      10. Intertek Group Plc
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
    11. APPENDIX
      1. References
      2. Related Reports
      3.  
    12. LIST OF TABLES
    13. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SYNOPSIS, 2018-2034
    14. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, ESTIMATES & FORECAST, 2018-2034 (USD BILLION)
    15. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    16. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    17. NORTH AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    18. NORTH AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    19. US: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    20. US: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    21. CANADA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    22. CANADA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    23. EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    24. EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    25. GERMANY: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    26. GERMANY: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    27. FRANCE: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    28. FRANCE: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    29. ITALY: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    30. ITALY: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    31. SPAIN: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    32. SPAIN: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    33. UK: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    34. UK: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    35. REST OF EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    36. REST OF EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    37. ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    38. ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    39. JAPAN: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    40. JAPAN: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    41. CHINA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    42. CHINA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    43. INDIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    44. INDIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    45. AUSTRALIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    46. AUSTRALIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    47. SOUTH KOREA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    48. SOUTH KOREA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    49. REST OF ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    50. REST OF ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    51. REST OF THE WORLD: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    52. REST OF THE WORLD: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    53. MIDDLE EAST: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    54. MIDDLE EAST: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    55. AFRICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    56. AFRICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    57. LATIN AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
    58. LATIN AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
    59. LIST OF FIGURES
    60. RESEARCH PROCESS
    61. MARKET STRUCTURE FOR THE GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET
    62. MARKET DYNAMICS FOR THE GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET
    63. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY SERVICE, 2022
    64. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY PHASE, 2022
    65. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
    66. NORTH AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
    67. EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
    68. ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
    69. REST OF THE WORLD: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
    70. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
    71. SGS SA: FINANCIAL OVERVIEW SNAPSHOT
    72. SGS SA: SWOT ANALYSIS
    73. LABCORP: FINANCIAL OVERVIEW SNAPSHOT
    74. LABCORP: SWOT ANALYSIS
    75. AMERICAN PRECLINICAL SERVICES: FINANCIAL OVERVIEW SNAPSHOT
    76. AMERICAN PRECLINICAL SERVICES: SWOT ANALYSIS
    77. STERIGENICS INTERNATIONAL LLC: FINANCIAL OVERVIEW SNAPSHOT
    78. STERIGENICS INTERNATIONAL LLC: SWOT ANALYSIS
    79. CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
    80. CHARLES RIVER LABORATORIES: SWOT ANALYSIS
    81. ELEMENT MINNETONKA: FINANCIAL OVERVIEW SNAPSHOT
    82. ELEMENT MINNETONKA: SWOT ANALYSIS
    83. NORTH AMERICA SCIENCE ASSOCIATES INC: FINANCIAL OVERVIEW SNAPSHOT
    84. NORTH AMERICA SCIENCE ASSOCIATES INC: SWOT ANALYSIS
    85. EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
    86. EUROFINS SCIENTIFIC: SWOT ANALYSIS
    87. PACE ANALYTICAL SERVICES LLC: FINANCIAL OVERVIEW SNAPSHOT
    88. PACE ANALYTICAL SERVICES LLC: SWOT ANALYSIS
    89. INTERTEK GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT
    90. INTERTEK GROUP PLC: SWOT ANALYSIS

    Market Segmentation Tab

    Medical Device Testing Services Service Outlook (USD Billion, 2018-2034)

    • Biocompatibility Tests
    • Chemistry Test
    • Microbiology & Sterility Test

    Medical Device Testing Services Phase Outlook (USD Billion, 2018-2034)

    • Preclinical
    • Clinical

    Medical Device Testing Services Regional Outlook (USD Billion, 2018-2034)

    • North America Outlook (USD Billion, 2018-2034)
      • North America Medical Device Testing Services by Service
        • Biocompatibility Tests
        • Chemistry Test
        • Microbiology & Sterility Test
      • North America Medical Device Testing Services by Phase
        • Preclinical
        • Clinical
      • US Outlook (USD Billion, 2018-2034)
      • US Medical Device Testing Services by Service
        • Biocompatibility Tests
        • Chemistry Test
        • Microbiology & Sterility Test
      • US Medical Device Testing Services by Phase
        • Preclinical
        • Clinical
      • CANADA Outlook (USD Billion, 2018-2034)
      • CANADA Medical Device Testing Services by Service
        • Biocompatibility Tests
        • Chemistry Test
        • Microbiology & Sterility Test
      • CANADA Medical Device Testing Services by Phase
        • Preclinical
        • Clinical
      • Europe Outlook (USD Billion, 2018-2034)
        • Europe Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • Europe Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • Germany Outlook (USD Billion, 2018-2034)
        • Germany Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • Germany Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • France Outlook (USD Billion, 2018-2034)
        • France Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • France Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • UK Outlook (USD Billion, 2018-2034)
        • UK Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • UK Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • ITALY Outlook (USD Billion, 2018-2034)
        • ITALY Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • ITALY Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • SPAIN Outlook (USD Billion, 2018-2034)
        • Spain Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • Spain Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • Rest Of Europe Outlook (USD Billion, 2018-2034)
        • Rest Of Europe Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • REST OF EUROPE Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • Asia-Pacific Outlook (USD Billion, 2018-2034)
          • Asia-Pacific Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • Asia-Pacific Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • China Outlook (USD Billion, 2018-2034)
          • China Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • China Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • Japan Outlook (USD Billion, 2018-2034)
          • Japan Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • Japan Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • India Outlook (USD Billion, 2018-2034)
          • India Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • India Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • Australia Outlook (USD Billion, 2018-2034)
          • Australia Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • Australia Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • Rest of Asia-Pacific Outlook (USD Billion, 2018-2034)
          • Rest of Asia-Pacific Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • Rest of Asia-Pacific Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • Rest of the World Outlook (USD Billion, 2018-2034)
            • Rest of the World Medical Device Testing Services by Service
              • Biocompatibility Tests
              • Chemistry Test
              • Microbiology & Sterility Test
            • Rest of the World Medical Device Testing Services by Phase
              • Preclinical
              • Clinical
            • Middle East Outlook (USD Billion, 2018-2034)
            • Middle East Medical Device Testing Services by Service
              • Biocompatibility Tests
              • Chemistry Test
              • Microbiology & Sterility Test
            • Middle East Medical Device Testing Services by Phase
              • Preclinical
              • Clinical
            • Africa Outlook (USD Billion, 2018-2034)
            • Africa Medical Device Testing Services by Service
              • Biocompatibility Tests
              • Chemistry Test
              • Microbiology & Sterility Test
            • Africa Medical Device Testing Services by Phase
              • Preclinical
              • Clinical
            • Latin America Outlook (USD Billion, 2018-2034)
            • Latin America Medical Device Testing Services by Service
              • Biocompatibility Tests
              • Chemistry Test
              • Microbiology & Sterility Test
            • Latin America Medical Device Testing Services by Phase
              • Preclinical
              • Clinical
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027